NEW YORK (GenomeWeb News) – A federal court judge has granted Illumina's motion for summary judgment that its sequencing technology does not infringe three Life Technologies patents.

In the decision handed down on Wednesday, Judge Cathy Ann Bencivengo of the US District Court for the Southern District of California said that Illumina does not infringe US Patent Nos. 5,616,478; 5,958,698; and 6,001,568 held by Life Technologies.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.